Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49366
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVanhentenrijk, S-
dc.contributor.authorVERBEECK, Johan-
dc.contributor.authorKalpakos, T-
dc.contributor.authorVandoren, Vincent-
dc.contributor.authorBraeckeveldt, L-
dc.contributor.authorL'Hoyes, W-
dc.contributor.authorChoustoulakis, E-
dc.contributor.authorRoosens, B-
dc.contributor.authorTang, WHW-
dc.contributor.authorVERWERFT, Jan-
dc.contributor.authorVERBRUGGE, Frederik-
dc.date.accessioned2026-06-22T10:22:45Z-
dc.date.available2026-06-22T10:22:45Z-
dc.date.issued2025-
dc.date.submitted2026-06-22T10:17:57Z-
dc.identifier.citationJournal of Cardiac Failure, 31 (4) , p. 651 -660-
dc.identifier.urihttp://hdl.handle.net/1942/49366-
dc.description.abstractTo evaluate whether early-combination diuretic therapy guided by serial post-diuretic urine sodium concentration (UNa+) assessments in acute heart failure (AHF) facilitates safe and effective decongestion.-
dc.description.sponsorshipFunding Roche diagnostics has provided an undisclosed research grant to cover the costs of biomarker analyses in the DECONGEST study, including all assessments of N-terminal pro-hormone of B-type natriuretic peptide (NT-proBNP), Cystatin C (CysC) and Cancer antigen 125 (CA-125). The Fund for Cardiac Surgery provided support to cover 10,000€ of running costs for the DECONGEST study (Ref. 489722). Acknowledgments The DECONGEST steering committee expresses its gratitude to Ingrid Lemoine and Julie Bollen, who, as site coordinators, helped to prepare and submit the files for ethical approval at University Hospital Brussels and Jessa Hospitals, respectively.-
dc.language.isoen-
dc.publisherCHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS-
dc.subject.otherCardio-renal syndrome-
dc.subject.otherdiuretics-
dc.subject.otherheart failure-
dc.subject.othernatriuresis-
dc.subject.othernatriuretic peptides-
dc.subject.othersodium-
dc.titleRationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study-
dc.typeJournal Contribution-
dc.identifier.epage660-
dc.identifier.issue4-
dc.identifier.spage651-
dc.identifier.volume31-
local.bibliographicCitation.jcatA1-
local.publisher.placeCURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.cardfail.2024.08.044-
dc.identifier.pmid39218247-
dc.identifier.isi001465914600001-
local.provider.typeWeb of Science-
local.uhasselt.internationalyes-
item.contributorVanhentenrijk, S-
item.contributorVERBEECK, Johan-
item.contributorKalpakos, T-
item.contributorVandoren, Vincent-
item.contributorBraeckeveldt, L-
item.contributorL'Hoyes, W-
item.contributorChoustoulakis, E-
item.contributorRoosens, B-
item.contributorTang, WHW-
item.contributorVERWERFT, Jan-
item.contributorVERBRUGGE, Frederik-
item.accessRightsClosed Access-
item.fulltextNo Fulltext-
item.fullcitationVanhentenrijk, S; VERBEECK, Johan; Kalpakos, T; Vandoren, Vincent; Braeckeveldt, L; L'Hoyes, W; Choustoulakis, E; Roosens, B; Tang, WHW; VERWERFT, Jan & VERBRUGGE, Frederik (2025) Rationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study. In: Journal of Cardiac Failure, 31 (4) , p. 651 -660.-
crisitem.journal.issn1071-9164-
crisitem.journal.eissn1532-8414-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.